Alessandro Federico Selected Research

Ribavirin (Virazole)

1/2017	ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.
6/2015	Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study.
3/2014	Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis.
12/2008	The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Federico Research Topics

Disease

22	Non-alcoholic Fatty Liver Disease 01/2022 - 07/2005
19	Fibrosis (Cirrhosis) 01/2022 - 09/2007
17	Liver Diseases (Liver Disease) 01/2022 - 01/2003
10	Inflammation (Inflammations) 06/2022 - 12/2007
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 09/2007
9	Neoplasms (Cancer) 08/2020 - 12/2007
7	Infections 08/2020 - 07/2012
6	Insulin Resistance 06/2022 - 05/2012
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2015
4	Alcoholism (Alcohol Abuse) 05/2021 - 05/2015
4	Necrosis 03/2021 - 03/2010
4	Fatty Liver 01/2018 - 09/2007
3	Alcoholic Fatty Liver 12/2021 - 07/2017
3	Obesity 04/2021 - 01/2019
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2021 - 01/2017
3	Hepatitis 01/2018 - 01/2012
3	Chronic Hepatitis (Chronic Active Hepatitis) 06/2015 - 12/2008
2	Alopecia (Baldness) 03/2021 - 01/2020
2	Pain (Aches) 01/2021 - 09/2008
2	Hypertension (High Blood Pressure) 01/2021 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 07/2013
2	Body Weight (Weight, Body) 01/2016 - 05/2012
2	Chronic Hepatitis C 01/2016 - 09/2012
1	Dyspepsia (Indigestion) 01/2022
1	COVID-19 04/2021
1	Ischemia 03/2021
1	Breast Neoplasms (Breast Cancer) 03/2021
1	Pruritus (Itching) 01/2021
1	Prolapse 01/2021
1	Hemorrhoids 01/2021
1	Hemorrhage 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Edema (Dropsy) 01/2021
1	Lichen Planus (Lichen Ruber Planus) 12/2020

Drug/Important Bio-Agent (IBA)

11	Silybin (Lagosa)IBA 01/2022 - 09/2007
8	AntioxidantsIBA 03/2021 - 01/2003
7	Antiviral Agents (Antivirals)IBA 05/2020 - 06/2015
7	CytokinesIBA 01/2016 - 01/2005
6	Vitamin E FDA LinkGeneric 01/2021 - 01/2003
5	LipidsIBA 03/2021 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2016
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 01/2005
4	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 12/2008
4	InterferonsIBA 01/2017 - 12/2008
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
3	Pharmaceutical PreparationsIBA 05/2021 - 03/2008
3	EnzymesIBA 03/2021 - 09/2007
3	Vitamin D FDA LinkGeneric 01/2021 - 01/2019
3	Glutathione (Reduced Glutathione)IBA 01/2021 - 01/2003
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 09/2007
3	Biological ProductsIBA 08/2020 - 01/2012
3	urotensin IIIBA 03/2020 - 01/2014
3	Clarithromycin (Biaxin)FDA LinkGeneric 01/2014 - 07/2012
2	Insulin (Novolin)FDA Link 06/2022 - 01/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 12/2020
2	Hormones (Hormone)IBA 03/2021 - 01/2019
2	PhytochemicalsIBA 01/2021 - 02/2017
2	PolyphenolsIBA 01/2021 - 02/2017
2	Alanine Transaminase (SGPT)IBA 12/2020 - 01/2018
2	Thiobarbituric Acid Reactive SubstancesIBA 12/2020 - 01/2019
2	bisphenol AIBA 12/2020 - 01/2019
2	CarcinogensIBA 08/2020 - 07/2013
2	Ethanol (Ethyl Alcohol)IBA 08/2020 - 01/2016
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2017 - 01/2016
2	Phosphatidylcholines (Phosphatidylcholine)IBA 07/2017 - 05/2012
2	Messenger RNA (mRNA)IBA 01/2014 - 05/2013
2	Amoxicillin (Wymox)FDA LinkGeneric 07/2013 - 07/2012
2	Immunoglobulin A (IgA)IBA 06/2013 - 09/2012
2	Interleukin-6 (Interleukin 6)IBA 03/2010 - 01/2005
2	S-NitrosothiolsIBA 03/2010 - 01/2005
2	Free RadicalsIBA 12/2007 - 01/2003
1	CalciumIBA 01/2022
1	SodiumIBA 01/2022
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2022
1	MagnesiumIBA 01/2022
1	Sulfates (Sulfates, Inorganic)IBA 01/2022
1	FructoseIBA 04/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2021
1	ResveratrolIBA 03/2021
1	Cetirizine (Zyrtec)FDA LinkGeneric 03/2021
1	palbociclibIBA 03/2021
1	CholesterolIBA 01/2021
1	AldehydesIBA 01/2021
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2021
1	Glycocholic AcidIBA 01/2021
1	Branched-Chain Amino AcidsIBA 01/2021
1	Diosmin (Daflon)IBA 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021

Therapy/Procedure

23	Therapeutics 01/2022 - 07/2005
3	Drug Therapy (Chemotherapy) 03/2020 - 02/2017
2	Mediterranean Diet 04/2021 - 02/2017
2	Liver Transplantation 03/2021 - 11/2019
2	Duration of Therapy 10/2019 - 07/2013
1	Transjugular Intrahepatic Portasystemic Shunt 12/2021
1	Continuity of Patient Care 09/2021
1	Immunotherapy 09/2021
1	Oral Administration 01/2021